RxDoctor Payments Data

Stephanie Bynum, MD

Family Medicine · Hattiesburg, MSNPI 1609041532

Payments from drug & device makers

$4,194in general payments, 2019–2025

Across 273 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$405
  • Lilly USA, LLC$337
  • AstraZeneca$261
  • Novo Nordisk$219
  • Abbott$207
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$4,194100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,194 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$70,143
Medicare patients
148
Services billed
1,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin91$107,854
LinzessLinaclotide66$71,293
MounjaroTirzepatide35$46,142
FarxigaDapagliflozin Propanediol38$41,518
JanuviaSitagliptin Phosphate19$26,250
OzempicSemaglutide15$25,756
TrulicityDulaglutide12$23,777
TradjentaLinagliptin24$23,066
EliquisApixaban12$18,214
JanumetSitagliptin Phos/Metformin Hcl19$13,561
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,627
ShingrixVaricella-Zoster Ge/As01b/Pf42$9,553
VascepaIcosapent Ethyl11$8,974
MyrbetriqMirabegron13$8,317
Valsartan160$5,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$132$130,919115 claims
AbbVieLinzess, Synthroid$1,365$74,65197 claims
Lilly USA, LLCMounjaro, Trulicity$337$69,92047 claims
AstraZenecaFarxiga, Breztri Aerosphere$261$52,14555 claims
MerckJanuvia, Janumet$41$39,81138 claims
Novo NordiskOzempic$219$25,75615 claims
PfizerEliquis$405$18,21412 claims
GSKShingrix$38$9,55342 claims
Astellas Pharma US IncMyrbetriq$15$8,31713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →